Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2129-2141

  Al Ali, Samer Hasan Hussein ^a   Al Qubaisi, Mothanna ^a   Hussein, Mohd Zobir ^a   Ismail, Maznah ^a   Zainal, Zulkarnain ^a   Hakim, Muhammad Nazrul ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Angiotensin converting enzyme; Coprecipitation; Ion exchange; Layered double hydroxides; Perindopril erbumine; Sustained release

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXIDE; NANOCOMPOSITE; PERINDOPRIL TERT BUTYLAMINE; ALUMINUM DERIVATIVE; ALUMINUM NITRATE; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERCALATING AGENT; METAL NANOPARTICLE; NITRATE; PERINDOPRIL; ZINC;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; ENZYME INHIBITION; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; ION EXCHANGE; STRUCTURE ANALYSIS; THERMOSTABILITY; X RAY DIFFRACTION; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECT; HUMAN; LIVER CELL; NANOMEDICINE; POWDER DIFFRACTION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; ULTRASTRUCTURE;

ALUMINUM COMPOUNDS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CELL LINE; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; HEPATOCYTES; HUMANS; INTERCALATING AGENTS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; NANOCOMPOSITES; NANOMEDICINE; NITRATES; PERINDOPRIL; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; ZINC;

EID: 84861562073     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S30461     Document Type: Article

References (48)

1. Rathbone MJ, Hadgraft J, Roberts MS. Modified-Release Drug Delivery Technology. Volume 126. New York, NY: Marcel Dekker; 2003.
2. Neeraj V, Taehong M, Rhul M, et al. Development of PEGylated PLGA nanoparticles for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnology. 2010;8(22):1-18.
3. Choi S-J, Choy J-H. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. Nanomedicine. 2011;6(5):803-814.
4. Shi W, Wei M, Jin L, Li C. Calcined layered double hydroxides as a "biomolecular vessel" for bromelain: immobilization, storage and release. J Mol Catal B Enzym. 2007;47(1-2):58-65.
5. Williams GR, O'Hare D. Towards understanding, control and application of layered double hydroxide chemistry. J Mater Chem. 2006;16(30):3065-3074.
6. 2 Al layered double hydroxides containing 5-fluorouracil. J Solid State Chem. 2005;178(3):736-741.
7. Li B, He J, Gevans D, Duan X. Inorganic layered double hydroxides as a drug delivery system-intercalation and in vitro release of fenbufen. Appl Clay Sci. 2004;27(3-4):199-207.
8. Xia SJ, Ni ZM, Xu Q, Hu BX, Hu J. Layered double hydroxides as supports for intercalation and sustained release of antihypertensive drugs. J Solid State Chem. 2008;181(10):2610-2619.
9. Panda HS, Srivastava R, Bahadur D. In-vitro release kinetics and stability of anticardiovascular drugs-intercalated layered double hydroxide nanohybrids. J Phys Chem B. 2009;113(45):15090-15100.
10. Opie LH. Angiotensin-Converting Enzyme Inhibitors: Scientific Basis for Clinical Use. Volume 2. 2nd ed. New York, NY: Wiley-Liss New York; 1994.
11. Pascard C, Guilhem J, Vincent M, Remond G, Portevin B, Laubie M. Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships. J Med Chem. 1991;34(2):663-669.
12. Hussein MZ, Al Ali SH, Zainal Z, Hakim MN. Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Int J Nanomedicine. 2011;6: 1373-1383.
13. Al Ali SHH, Al-Qubaisi M, Hussein MZ, Zainal Z, Hakim MN. Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines. Int J Nanomedicine. 2011;6:3099-3111.
14. Miyata S. Hydrotalcites in relation to composition. Clays Clay Miner. 1980;28(1):50-56.
15. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology. 1971;20(7):1637-1648.
16. Tang P, Xu X, Lin Y, Li D. Enhancement of the thermo-and photostability of an anionic dye by intercalation in a zinc-aluminum layered double hydroxide host. Ind Eng Chem Res. 2008;47(8):2478-2483.
17. Kong X, Shi S, Han J, Zhu F, Wei M, Duan X. Preparation of glycy-L-tyrosine intercalated layered double hydroxide film and its in vitro release behavior. Chem Eng J. 2010;157(2-3):598-604.
18. Cavani F, Trifiro F, Vaccari A. Hydrotalcite-type anionic clays: Preparation, properties and applications. Catal Today. 1991;11(2): 173-301.
19. Meyn M, Beneke K, Lagaly G. Anion-exchange reactions of layered double hydroxides. Inorg Chem. 1990;29(26):5201-5207.
20. Carbajal Arizaga GG, Wypych F, Castillon Barraza F, Contreras Lopez OE. Reversible intercalation of ammonia molecules into a layered double hydroxide structure without exchanging nitrate counter-ions. J Solid State Chem. 2010;183(10):2324-2328.
21. Hussein MZ, Hwa TK. Synthesis and properties of layered organicinorganic hybrid material: Zn-Al layered double hydroxide-dioctyl sulfosuccinate nanocomposite. J Nanopart Res. 2000;2(3):293-298.
22. Kipkemboi PK, Kiprono PC, Sanga JJ. Vibrational spectra of t-butyl alcohol, t-butylamine and t-butyl alcohol--t-butylamine binary liquid mixtures. B Chem Soc Ethiopia. 2003;17(2):211-218.
23. Smith BC. Infrared Spectral Interpretation: A Systematic Approach. Boca Raton, FL: CRC; 1999.
24. Milan R. Molecular structure and stability of perindopril erbumine and perindopril l-arginine complexes. Eur J Med Chem. 2009;44(1): 101-108.
25. Tronto J, Reis MJD, Silverio F, Balbo VR, Marchetti JM, Valim JB. In vitro release of citrate anions intercalated in magnesium aluminium layered double hydroxides. J Phys Chem Solids. 2004;65(2-3): 475-480.
26. Kempa TJ, Barton ZM, Cunliffe AV. Mechanism of the thermal degradation of prepolymeric poly(3-nitratomethyl-3-methyloxetane). Polymer. 1999;40(1):65-93.
27. Kir'yalov N, Amirova G. Triterpene acids from the roots of Meristotropis triphylla Fisch. et Mey. Chem Nat Compd. 1965;1(5):243-245.
28. Morzyk-Ociepa B, Michalska D, Pietraszko A. Structures and vibrational spectra of indole carboxylic acids. Part I. Indole-2-carboxylic acid. J Mol Struct. 2004;688(1-3):79-86.
29. Yuan Q, Wei M, Evans DG, Duan X. Preparation and investigation of thermolysis of L-aspartic acid-intercalated layered double hydroxide. J Phys Chem B. 2004;108(33):12381-12387.
30. Rives V. Layered Double Hydroxides: Present and Future. New York, NY: Nova Science Publishing Inc; 2001.
31. Kloprogge JT, Frost RL. Fourier transform infrared and Raman spectroscopic study of the local structure of Mg-, Ni-, and Co-hydrotalcites. J Solid State Chem. 1999;146(2):506-515.
32. Macêdo RO, Gomes do Nascimento T, Soares Arago CF, Barreto Gomes AP. Application of thermal analysis in the characterization of anti-hypertensive drugs. J Therm Anal Calorim. 2000;59(3):657-661.
33. Cheng X, Huang X, Wang X, Sun D. Influence of calcination on the adsorptive removal of phosphate by Zn-Al layered double hydroxides from excess sludge liquor. J Hazard Mater. 2010;177(1-3):516-523.
34. Ajat M, Mohd M, Yusoff K, Hussein MZ. Synthesis of glutamatezinc-aluminium-layered double hydroxide nanobiocomposites and cell viability study. Curr Nanosci. 2008;4(4):391-396.
35. Vicente R. Characterisation of layered double hydroxides and their decomposition products. Mater Chem Phys. 2002;75(1-3):19-25.
36. Pierotti RA, Rouquerol J. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity. Pure Appl Chem. 1985;57(4):603-619.
37. Raki L, Beaudoin JJ, Mitchell L. Layered double hydroxide-like materials: nanocomposites for use in concrete. Cem Concr Res. 2004; 34(9):1717-1724.
38. Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 2001;73(2-3):121-136.
39. Bin Hussein MZ, Zainal Z, Yahaya AH, Foo DWV. Controlled release of a plant growth regulator,[alpha]-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J Control Release. 2002;82(2-3):417-427.
40. Ambrogi V, Fardella G, Grandolini G, Perioli L, Tiralti MC. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: uptake of diclofenac for a controlled release formulation. AAPS Pharm Sci Tech. 2002;3(3):77-82.
41. Dong L, Yan L, Hou W-G, Liu S-J. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183(8):1811-1816.
42. Hou WG, Jin ZL. Synthesis and characterization of naproxen intercalated Zn-Al layered double hydroxides. Colloid Polym Sci. 2007; 285(13):1449-1454.
43. Wei M, Pu M, Guo J, et al. Intercalation of L-dopa into layered double hydroxides: enhancement of both chemical and stereochemical stabilities of a drug through host-guest interactions. Chem Mater. 2008; 20(16):5169-5180.
44. Kodama T, Harada Y, Ueda M, Shimizu K-I, Shuto K, Komarneni S. Selective exchange and fixation of strontium ions with ultrafine Na-4-mica. Langmuir. 2001;17(16):4881-4886.
45. Posati T, Bellezza F, Tarpani L, et al. Selective internalization of ZnAl-HTlc nanoparticles in normal and tumor cells. A study of their potential use in cellular delivery. Appl Clay Sci. 2012;55(0):62-69.
46. Chrysant SG, McDonald RH, Wright JT, Barden PL, Weiss RJ. Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. Clin Pharmacol Ther. 1993;53(4):479-484.
47. Rahman N, Anwar N, Kashif M. Optimized and validated initial-rate method for the determination of perindopril erbumine in tablets. Chem Pharm Bull. 2006;54(1):33-36.
48. Sica DA. Dosage considerations with perindopril for systemic hypertension. Am J Cardiol. 2001;88(7):13-18.